LITTLETON, Mass. -- (BUSINESS WIRE) -- Mevion Medical Systems announced today the delivery of its revolutionary MEVION S250 proton therapy superconducting synchrocyclotron accelerator to the world’s first physician-owned proton therapy center at First Coast Oncology in Jacksonville Florida.
The MEVION S250 proton therapy system is a unique proton therapy platform — a single-room, gantry-mounted proton accelerator that frees hospitals and private treatment facilities from the astronomical costs, prohibitive space requirements and cumbersome processes that to date have defined this effective treatment modality. Proton therapy benefits are defined by the ability to precisely deliver radiation doses to a tumor while greatly limiting unnecessary radiation to healthy tissues, and thus potentially improving patient outcomes and reducing associated side effects.
"It is exciting to see the positive clinical outcomes that proton therapy centers are having on patients throughout the world”, said Dr. Scot Ackerman, Radiation Oncologist and Medical Director of First Coast Oncology. "The installation of the MEVION S250 will benefit our patients and our entire community and I strongly believe this revolutionary radiation therapy device will greatly increase access to proton therapy for all communities."
“This is the first installation of a proton therapy system at a physician-owned cancer center and is another very significant achievement by Mevion that is changing the face of proton therapy“, said Joseph K. Jachinowski, Chief Executive Officer of Mevion Medical Systems. “The idea of a freestanding cancer center with it’s own proton therapy unit was unthinkable until now. The MEVION S250 advanced technology and flexible business model is truly expanding the accessibility and feasibility of proton therapy to every cancer center.”
After a four-day journey from Mevion’s headquarters outside Boston, the first-of-its-kind accelerator was delivered and mounted onto its rotating gantry the same day. Mevion’s experienced installation team will complete the installation and move into acceptance testing and commission of the system this year.
The MEVION S250 is also installed at the Kling Proton Therapy Center at Barnes-Jewish Hospital at Washington University in St. Louis, MO, and is treating pediatric patients and other cancer patients where proton therapy treatment is indicated.
Four additional MEVION S250 proton therapy systems are under installation at Robert Wood Johnson University Hospital in New Brunswick, N.J.; Stephenson Cancer Center at the University of Oklahoma in Oklahoma City, Okla.; University of Florida Health Cancer Center at Orlando Health; and University Hospitals Seidman Cancer Center in Cleveland, Ohio.
About First Coast Oncology
First Coast Oncology's mission is to be the first resource where patients turn when diagnosed with any type of cancer. We provide the most advanced radiation oncology treatment available, in a compassionate and respectful environment. A highly trained staff of Radiation Oncologists and medical professionals provide convenient access of care at three locations across Northeast Florida. Visit www.FirstCoastOncology.com for more information.
About Mevion Medical Systems
Mevion Medical Systems, Inc. is a radiation therapy company dedicated to advancing the treatment of cancer. As the pioneering developer of modern proton therapy, Mevion provides innovative, safe, and effective solutions by transforming advances in medical technology and science into practical clinical reality.
Mevion’s flagship product, the MEVION S250 Proton Therapy System, is designed to preserve all of the treatment benefits of traditional proton therapy systems while removing the obstacles of size, cost, and complexity. Realizing this vision, Mevion has forever changed the economics and accessibility of proton therapy worldwide.
Founded in 2004, Mevion is a privately held company headquartered in the Boston metropolitan area with international offices in the United Kingdom and Japan.
Visit us at: http://www.mevion.com